The telemedicine market is booming, and Teladoc is leading the way. From fresh IPOs to tech giants, we delve into its top three competitors.
Aug 27, 2021
After a recent IPO and an impressive inaugural quarterly report as a public company, we delve into three of Doximity’s competitors.
Aug 24, 2021
After the IPO madness we saw in 2020, what lessons can we utilize in 2021 to build a healthy investment strategy for this year’s IPO market
Jan 9, 2021
The race to dominate the telehealth space is heating up, so in this rapidly expanding market, which is a better investment: the first mover or the hot IPO?
Oct 3, 2020
The company should reap up to $560 million in gross proceeds from the issue.
Sep 9, 2020
One new telemedicine service has been given a boost from a massive stock-market player.
Aug 28, 2020